[1]
D. Setiawan, R. R. Tjandrawinata, Lianawati, Galar Sigit Prasuma, Andi Nurul Annisa, and Sidartawan Soegondo, “The Use of DLBS3233 Bioactive Fraction in Type 2 Diabetes Mellitus Management in Indonesia: A Cost-Effectiveness Analysis of Real-World Evidence”, Indonesian J Pharm, vol. 36, no. 3, pp. 571–582, Feb. 2025.